19-Nov-2009 - Continued high demand for vaccine manufacturing technologies saw life sciences emerge as one of the few positives for industrial processing specialist Pall in Q1.
18-Nov-2009 - UK process technologies firm Reaxa has received a £146K (€164K) R&D grant from the Northwest Regional Development Agency (NWDA) to scale-up production of its EnCat nickel catalyst.
16-Nov-2009 - A consortium including GlaxoSmithKline and GEA has been formed to push continuous processing and improve pharma manufacturing efficiency in the UK in response to competition from emerging markets.
12-Nov-2009 - French drug delivery specialist Galenix has named DSM’s pharmaceutical products unit as its manufacturing and co-marketing partner as it continues to efforts build its global presence.
05-Nov-2009 - US CMO PharmaForm has added spray-drying to its contract offering to capture a share of the ever-present market for drug bioavailability enhancement.
03-Nov-2009 - Novartis is investing $250m (€170m) to construct a facility in China focused on research, development and manufacture of APIs and has earmarked a further $1bn to expand its R&D activities in the country.
02-Nov-2009 - Phoenix Chemicals will re-open a chemicals manufacturing plant in Scotland less than a year after it was closed by former owner Shasun Pharma Solutions.
02-Nov-2009 - O’Hara Technologies has launched a lab-scale tablet coating system that incorporates a blender and tray dry oven inserts to cut capital expense and GMP spaced needed perform these tasks.
29-Oct-2009 - How successful was the BioPh conference in Madrid? in-PharmaTechnologist asked key players attending the inaugural event.
26-Oct-2009 - Portuguese CMO Hovione has bought an aseptic spray-drying line from US firm Acusphere and says that the demand for the technology is increasing as drug firms aim to boost bioavailability.
26-Oct-2009 - Micromeritics says its new European headquarters in Germany is better positioned to serve its expanding client base in the region.
26-Oct-2009 - Novavax has entered into a deal with Xcellerex to boost production of its H1N1 vaccine, which is entering clinical trials in Mexico, using the CMO’s FlexFactory disposable biomanufacturing platform.
22-Oct-2009 - BASF says its new Soluplus excipient will help meet demand for solubilising agents that are compatible with hot melt extrusion (HME) manufacturing methods.
22-Oct-2009 - GEA Niro has begun offering contract spray-drying services for drug candidates and clinical trial supplies from its “Test Center” in Copenhagen, Denmark and wants the drug industry to know about the technique’s advantages.
19-Oct-2009 - Arch Pharmalabs is continuing its push to serve innovative pharma by adding simulated moving bed (SMB) technology, becoming the first in India to offer the offer the system for plant scale API manufacture.
15-Oct-2009 - As CPhI 2009 draws to a close we take a look back on the show, which, despite some negatives, appears to have been an overall success.
14-Oct-2009 - Reaxa will set up an Indian subsidiary to manage supply chain, commercial scale production and application development for its growing number of customers in the country.
12-Oct-2009 - Millipore has expanded its Mobius process technology range with the new CellReady 3L bench-top bioreactor.
08-Oct-2009 - We look ahead to CPhI 2009 which takes place in Madrid, Spain next week and will showcase the world’s leading ingredients, contract services, machinery and biotech companies.
05-Oct-2009 - UK pharmaceutical test media supplier Cherwell Laboratories says its receipt of BSI ISO 9001:2008 accreditation demonstrates its commitment to quality.
30-Sep-2009 - Portuguese API maker Hovione says its contract manufacturing plant in Loures has passed a pre-approval inspection by the US Food and Drug Administration (FDA).
24-Sep-2009 - Ampac Fine Chemicals (AFC) has added three new commercial-scale Hastelloy liquid-liquid centrifuges to its API making business in a move that, it says, will increase batch size and lower manufacturing costs.
16-Sep-2009 - Revenues from Pall’s biopharmaceuticals division grew in fiscal 2009, excluding foreign currency changes, with the company benefiting from the “thriving market” for vaccines and expanding adoption of single-use systems.
10-Sep-2009 - Struggling biotech Targeted Genetics (TG) has sold certain patents and AAV manufacturing technology to fellow US group Genzyme in a $7m deal that “shifts the firm out of crisis mode,” according to CEO Susan Robinson.
03-Sep-2009 - Biotechnology firm Cel-Sci claims the “True Cold” low-temperature fill and finish service at its new manufacturing facility near Baltimore, Maryland is a first for the global contracting sector.